Global Adult Hemoglobinopathy Testing Market to Reach $513.7 Million by 2030 [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Adult Hemoglobinopathy Testing estimated at US$368.6 Million in the year 2022, is projected to reach a revised size of US$513.7 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2022-2030. HPLC Test, one of the segments analyzed in the report, is projected to record 3.9% CAGR and reach US$314.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Mass Spectrometry segment is readjusted to a revised 4.4% CAGR for the next 8-year period. The U.S. Market is Estimated at $98.2 Million, While China is Forecast to Grow at 6.6% CAGR The Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$98.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$110.4 Million by the year 2030 trailing a CAGR of 6.6% over the analysis per
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Bio-Rad Announces Life Science Group Management ChangesBusiness Wire
- Bio-Rad Laboratories, Inc. (NYSE: BIO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Digital PCR and Quantitative PCR Market Report 2024 - Global Trends, Forecast and Competitive Analysis to 2030 [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits? [Yahoo! Finance]Yahoo! Finance
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024Business Wire
BIO
Earnings
- 2/15/24 - Beat
BIO
Sec Filings
- 4/26/24 - Form 8-K
- 4/17/24 - Form 3
- 4/10/24 - Form 8-K
- BIO's page on the SEC website